MedPath
NMPA Approval

Atomoxetine Hydrochloride Capsules

国药准字HJ20220062

June 30, 2022

Drug Information

盐酸托莫西汀胶囊

胶囊剂

40mg(按C₁₇H₂₁NO计)

化学药品

June 30, 2022

June 29, 2027

Company Information

Applicant Company

FTO Unit 3, Survey No. 41, 42 Part, 45 Part & 46 Part, Bachupally Village and Mandal, Medchal-Malkajgiri District-500090 Telangana, India

Manufacturing Company

FTO Unit 3, Survey No. 41, 42 Part, 45 Part & 46 Part, Bachupally Village and Mandal, Medchal-Malkajgiri District-500090 Telangana, India

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

盐酸托莫西汀胶囊 - NMPA 批准文号 | MedPath